ArticleDigital health
HealthLINE: A messaging chatbot for supporting chronic disease self-management.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A Scoping Review of Digital Behavioral Approaches to Improve Medication Adherence in Type 2 Diabetes.Current diabetes reports · 2026Article
- Article
- Review
Corrections and comments
- Retracted
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic diseases such as hypertension and diabetes require ongoing lifestyle management, but traditional health education methods are limited by accessibility and resource constraints. Digital health tools, particularly chatbots embedded in widely used messaging platforms like LINE, offer scalable and continuous support for self-management. Objective: This study aimed to design, implement, and evaluate Methods: An 8-week action research study was conducted with 40 adults diagnosed with hypertension or type 2 diabetes. Participants used Results: Participants interacted with the chatbot an average of 4.2 times per day. System acceptance was high, with perceived usefulness ( Conclusions: The
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.